Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel

International Journal of Pharmaceutics

Volumn 427, Issue 2, 2012, Pages 299-304

  Ozeki, Tetsuya ^a   Kaneko, Daiki ^b   Hashizawa, Kosuke ^b   Imai, Yoshihiro ^b   Tagami, Tatsuaki ^a   Okada, Hiroaki ^b  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Glioma therapy; Poly (lactic co glycolic acid) (PLGA) microspheres; Sustained release; Thermoreversible gelation polymer (TGP); Vincristine

Indexed keywords

CAMPTOTHECIN; POLYGLACTIN; POLYMER; THERMOREVERSIBLE GELATION POLYMER; UNCLASSIFIED DRUG; VINCRISTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; ENCAPSULATION; GLIOMA; HYDROGEL; MALE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE; THERMOSTABILITY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRAIN; BRAIN NEOPLASMS; CAMPTOTHECIN; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; FLUORESCEIN-5-ISOTHIOCYANATE; GLIOMA; HOT TEMPERATURE; HYDROGELS; LACTIC ACID; MALE; MICROSPHERES; POLYGLYCOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; VINCRISTINE;

EID: 84859106119     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.02.012     Document Type: Article

References (26)

1. S.D. Allison Effect of structural relaxation on the preparation and drug release behavior of poly(lactic-co-glycolic)acid microparticle drug delivery systems J. Pharm. Sci. 97 2008 2022 2035
2. T. Arai, T. Joki, M. Akiyama, M. Agawa, Y. Mori, H. Yoshioka, and T. Abe Novel drug delivery system using thermoreversible gelation polymer for malignant glioma J. Neurooncol. 77 2006 9 15
3. C.E. Astete, and C.M. Sabliov Synthesis and characterization of PLGA nanoparticles J. Biomater. Sci. Polym. Ed. 17 2006 247 289
4. M.M. de Aquino Gorayeb, S. Aisen, W. Nadalin, R. Panico Gorayeb, and H. de Andrade Carvalho Treatment of childhood diffuse brain stem tumors: comparison of results in different treatment modalities Clin. Transl. Oncol. 8 2006 45 49
5. C.R. Freeman, and G. Perilongo Chemotherapy for brain stem gliomas Childs Nerv. Syst. 15 1999 545 553
6. H.S. Friedman, S.T. Keir, and P.J. Houghton The emerging role of irinotecan (CPT-11) in the treatment of malignant glioma in brain tumors Cancer 97 Suppl. 2003 2359 2362
7. C. Guerin, A. Olivi, J.D. Weingart, H.C. Lawson, and H. Brem Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers Invest. New Drugs 22 2004 27 37
8. C. Jean-Decoster, L. Brichese, J.M. Barret, Y. Tollon, A. Kruczynski, B.T. Hill, and M. Wright Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells Anticancer Drugs 10 1999 537 543
9. A. Kruczynski, F. Colpaert, J.P. Tarayre, P. Mouillard, J. Fahy, and B.T. Hill Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid Cancer Chemother. Pharmacol. 41 1998 437 447
10. S.K. Lim, S.R. Llaguno, R.M. McKay, and L.F. Parada Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models BMB Rep. 44 2011 158 164
11. R.C. Mundargi, V.R. Babu, V. Rangaswamy, P. Patel, and T.M. Aminabhavi Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives J. Control. Release 125 2008 193 209
12. V.K. Ngan, K. Bellman, D. Panda, B.T. Hill, M.A. Jordan, and L. Wilson Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules Cancer Res. 60 2000 5045 5051
13. H. Okada, T. Heya, Y. Ogawa, and T. Shimamoto One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats J. Pharmacol. Exp. Ther. 244 1988 744 750
14. T. Ozeki, S. Beppu, T. Mizoe, Y. Takashima, H. Yuasa, and H. Okada Preparation of polymeric submicron particle-containing microparticles using a 4-fluid nozzle spray drier Pharm. Res. 23 2006 177 183
15. T. Ozeki, K. Hashizawa, D. Kaneko, Y. Imai, and H. Okada Treatment of rat brain tumors using sustained-release of camptothecin from poly(lactic-co- glycolic acid) microspheres in a thermoreversible hydrogel Chem. Pharm. Bull. (Tokyo) 58 2010 1142 1147
16. V. Pavillard, D. Kherfellah, S. Richard, J. Robert, and D. Montaudon Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants Br. J. Cancer 85 2001 1077 1083
17. Y. Pommier, E. Leo, H. Zhang, and C. Marchand DNA topoisomerases and their poisoning by anticancer and antibacterial drugs Chem. Biol. 17 2010 421 433
18. B. Pourroy, M. Carre, S. Honore, V. Bourgarel-Rey, A. Kruczynski, C. Briand, and D. Braguer Low concentrations of vinflunine induce apoptosis in human SK-N-SH neuroblastoma cells through a postmitotic G1 arrest and a mitochondrial pathway Mol. Pharmacol. 66 2004 580 591
19. A. Quick, D. Patel, M. Hadziahmetovic, A. Chakravarti, and M. Mehta Current therapeutic paradigms in glioblastoma Rev. Recent Clin. Trials 5 2010 14 27
20. M. Sabel, and A. Giese Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience Curr. Med. Res. Opin. 24 2008 3239 3257
21. M. Santisteban, J.C. Buckner, J.M. Reid, W. Wu, B.W. Scheithauer, M.M. Ames, S.J. Felten, D.A. Nikcevich, M. Wiesenfeld, and K.A. Jaeckle Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results J. Neurooncol. 92 2009 165 175
22. A.J. Sawyer, J.M. Piepmeier, and W.M. Saltzman New methods for direct delivery of chemotherapy for treating brain tumors? Yale J. Biol. Med. 79 2006 141 152
23. H. Yoshioka, M. Mikami, Y. Mori, and E. Tsuchida A synthetic hydrogel with thermoreversible gelation I: preparation and rhological properties J. Macromol. Sci. A 31 1994 113 120
24. H. Yoshioka, M. Mikami, Y. Mori, and E. Tsuchida A synthetic hydrogel with thermoreversible gelation II: effect of added salts J. Macromol. Sci. A 31 1994 1201 1205
25. H. Yoshioka, M. Mikami, Y. Mori, and E. Tsuchida A synthetic hydrogel with thermoreversible gelation III: an NMR study of the sol-gel transition Polym. Adv. Technol. 1994 122 127
26. X.J. Zhou, and R. Rahmani Preclinical and clinical pharmacology of vinca alkaloids Drugs 44 Suppl. 4 1992 1 16 (discussion 66-9)